Author:
Hooker Andrew C.,Staatz Christine E.,Karlsson Mats O.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference22 articles.
1. L. Zhang, V. Sinha, S. T. Forgue, S. Callies, L. Ni, R. Peck, and S. R. Allerheiligen. Model-based drug development: the road to quantitative pharmacology. J. Pharmacokinet. Pharmacodyn. 33:369–393 (2006).
2. L. Aarons, M. O. Karlsson, F. Mentre, F. Rombout, J. L. Steimer, A. van Peer. Role of modelling and simulation in Phase I drug development. Eur. J. Pharm. Sci. 13:115–122 (2001).
3. J. C. Pinheiro, M. J. Lindstrom. Model building for nonlinear mixed effects models, (1994).
4. A. T. Galecki, R. D. Wolfinger, O. A. Linares, M. J. Smith, and J. B. Halter. Ordinary differential equation PK/PD models using the SAS macro NLINMIX. J. Biopharm. Stat. 14:483–503 (2004).
5. P. Girard and F. Mentré. A comparison of estimation methods in nonlinear mixed effects models using a blind analysis, PAGE Abstracts of the Annual Meeting of the Population Approach Group in Europe, Vol. 14, Abstr 834 [ http://www.page-meeting.org/?abstract=834 ], Pamplona, Spain, 2005.
Cited by
298 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献